Showcases Stock ranks Forex

Eli Lilly and Company (LLY)
147.44  2.69 (1.86%) 11-27 13:02
Open: 145.65 Pre. Close: 144.75
High: 147.92 Low: 145.36
Volume: 1,618,166 Market Cap: 141,038M
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; migraine and episodic cluster headache; attention-deficit hyperactivity disorder; and schizophrenia. In addition, it offers immunology products for the treatment of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and products to treat erectile dysfunction and benign prostatic hyperplasia. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; Dicerna Pharmaceuticals, Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; Duke Clinical Research Institute for the prevention of chronic heart failure and mortality after an acute myocardial infarction; AbCellera Biologics Inc.; and Sermonix Pharmaceuticals Inc., as well as an agreement with Junshi Biosciences to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 145.554 - 146.287 146.287 - 146.891
Low: 140.913 - 141.69 141.69 - 142.329
Close: 143.602 - 144.83 144.83 - 145.84
Stock Technical Analysis
Target: Six months: 177.51
One year: 207.33
Support: Support1: 137.91
Support2: 129.21
Resistance: Resistance1: 151.98
Resistance2: 177.51
Pivot: 143.41
Moving Averages: MA(5): 145.19
MA(20): 141.92
MA(100): 149.48
MA(250): 145.91
MACD: MACD(12,26): 0.61
Signal(12,26,9): -0.19
%K %D: %K(14,3): 66.63
%D(3): 62.73
RSI: RSI(14): 57.14
52-Week: High: 170.75
Low: 115.92
Change(%): 26.3
Average Vol(K): 3-Month: 411803
10-Days: 359676
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

LLY has closed below upper band by 2.7%. Bollinger Bands are 37.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Fri, 27 Nov 2020
Eli Lilly and Company (LLY) Rises 1.86% for November 27 -

Fri, 27 Nov 2020
Eli Lilly and Company (LLY)'s Stock is Jumping, Here is Why - The Oracle Dispatch

Tue, 24 Nov 2020
Should Value Investors Choose Eli Lilly and Co (LLY) Stock? - Yahoo Finance

Mon, 23 Nov 2020
why Eli Lilly and Company [LLY] is a Good Choice for Investors After New Price Target of $165.88 - The DBT News

Fri, 20 Nov 2020
Eli Lilly and Company (LLY) Presents Tirzepatide SURPASS Program Overview Conference (Transcript) - Seeking Alpha

Wed, 18 Nov 2020
Eli Lilly and Company (LLY) Presents at Wolfe Research Virtual Healthcare Conference (Transcript) - Seeking Alpha

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 956.58
Shares Float (M) 743.84
% Held by Insiders 0.16
% Held by Institutions 79.43
Shares Short (K) 4890
Shares Short Prior Month (K) 3770
Stock Financials
EPS 6.110
Book Value (p.s.) 5.320
Profit Margin 24.01
Operating Margin 27.76
Return on Assets (ttm) 9.8
Return on Equity (ttm) 131.8
Qtrly Rev. Growth 4.8
Gross Profit (p.s.) 18.399
Sales Per Share 24.264
EBITDA (p.s.) 8.091
Qtrly Earnings Growth -3.60
Operating Cash Flow (M) 6650.00
Levered Free Cash Flow (M) 4440.00
Stock Valuation
PE Ratio 24.13
PEG Ratio 1.11
Price to Book value 27.71
Price to Sales 6.08
Price to Cash Flow 21.21
Stock Dividends
Dividend 2.870
Dividend Yield 0.02
Dividend Growth 2.960

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator